References
- National Institute of Mental Health (NIMH). Major Depression, 2017. Available at: http://www.nimh.nih.gov/health/statistics/prevalence/major-depression-among-adults.shtml. [Last accessed October 4, 2018]
- Marvel CL, Paradiso S. Cognitive and neurological impairment in mood disorders. Psychiatr Clin North Am. 2004;27:19–36, vii–viii.
- Ferrari AJ, Charlson FJ, Norman RE, et al. Burden of depressive disorders by country, sex, age, and year: findings from the Global Burden of Disease Study 2010. PLoS Med. 2013;10:e1001547.
- Greenberg PE, Fournier AA, Sisitsky T, et al. The economic burden of adults with major depressive disorder in the United States (2005 and 2010). J Clin Psychiatry. 2015;76:155–162.
- Rush AJ, Kraemer HC, Sackeim HA, et al. Report by the ACNP Task Force on response and remission in major depressive disorder. Neuropsychopharmacology. 2006;31:1841–1853.
- Oluboka OJ, Katzman MA, Habert J, et al. Functional recovery in major depressive disorder: providing early optimal treatment for the individual patient. Int J Neuropsychopharmacol. 2018;21:128–144.
- Armstrong C. APA releases guideline on treatment of patients with major depressive disorder. Am Fam Physician. 2011;83:1219–1227.
- Kudlow PA, McIntyre RS, Lam RW. Early switching strategies in antidepressant non-responders: current evidence and future research directions. CNS Drugs. 2014;28:601–609.
- Oestergaard S, Moldrup C. Improving outcomes for patients with depression by enhancing antidepressant therapy with non-pharmacological interventions: a systematic review of reviews. Public Health. 2011;125:357–367.
- Paykel ES. Partial remission, residual symptoms, and relapse in depression. Dialogues Clin Neurosci. 2008;10:431–437.
- Hardeveld F, Spijker J, De Graaf R, et al. Recurrence of major depressive disorder across different treatment settings: results from the NESDA study. J Affect Disord. 2013;147:225–231.
- Burcusa SL, Iacono WG. Risk for recurrence in depression. Clin Psychol Rev. 2007;27:959–985.
- Sim K, Lau WK, Sim J, et al. Prevention of relapse and recurrence in adults with major depressive disorder: systematic review and meta-analyses of controlled trials. Neuropsychopharmacol. 2016;19:pyv076.
- Thaipisuttikul P, Ittasakul P, Waleeprakhon P, et al. Psychiatric comorbidities in patients with major depressive disorder. Neuropsychiatr Dis Treat. 2014;10:2097–2103.
- Sood N, Treglia M, Obenchain RL, et al. Determinants of antidepressant treatment outcome. Am J Manag Care. 2000;6:1327–1336.
- Quan H, Sundararajan V, Halfon P, et al. Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care. 2005;43:1130–1139.
- Quan H, Li B, Couris CM, et al. Updating and validating the Charlson comorbidity index and score for risk adjustment in hospital discharge abstracts using data from 6 countries. Am J Epidemiol. 2011;173:676–682.
- Gauthier G, Guérin A, Zhdanava M, et al. Treatment patterns, healthcare resource utilization, and costs following first-line antidepressant treatment in major depressive disorder: a retrospective US claims database analysis. BMC Psychiatry. 2017;17:222.
- Unützer J, Park M. Strategies to improve the management of depression in primary care. Prim Care. 2012;39:415–431.
- Van den Broeck K, Ketterer F, Remmen R, et al. Why collaborative care for depressed patients is so difficult: a Belgian qualitative study. Int J Integr Care. 2017;17:7.
- Fortney JC, Unutzer J, Wrenn G, et al. A tipping point for measurement-based care. Psychiatr Serv. 2017;68:179–188.
- Solem CT, Shelbaya A, Wan Y, et al. Analysis of treatment patterns and persistence on branded and generic medications in major depressive disorder using retrospective claims data. Neuropsychiatr Dis Treat. 2016;12:2755–2764.